BSX Filing
8-KFiling Date: Jul 29, 2026

BOSTON SCIENTIFIC CORP (BSX) · Material Event (8-K) SEC Filing

Earnings Release, Financial Statements

descriptionView SEC Filing
ACC: 0000885725-26-000051open_in_new

Event Type

Earnings ReleaseFinancial Statements
description

Event Description

Item 2.02. Earnings Release
expand_more

Boston Scientific (BSX) reported Q2 2026 financial results on July 29, 2026, via a press release furnished as Exhibit 99.1. The announcement covers results for the quarter ended June 30, 2026.

Original SEC Filing Text expand_more
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On July 29, 2026, Boston Scientific Corporation issued a press release announcing financial results for the second quarter ended June 30, 2026. A copy of the release is furnished with this report as Exhibit 99.1. The information contained in
description

Event Description

Item 9.01. Financial Statements
expand_more

Boston Scientific Corporation filed an 8-K on July 29, 2026, to furnish a press release (Exhibit 99.1) of the same date. The press release likely contains material financial or corporate information, though the specific content is not detailed in the filing.

Original SEC Filing Text expand_more
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by Boston Scientific Corporation dated July 29, 2026 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 29, 2026 BOSTON SCIENTIFIC CORPORATION By: /s/ Susan Thompson Susan Thompson Vice President, Chief Corporate Counsel and Assistant Secretary

keid AI analysis is for reference only and does not constitute investment advice.